Overview
  • Contains 100 mg/ml of tulathromycin
  • Indicated for the treatment of bovine respiratory disease (BRD) and for the control of respiratory disease in cattle at high risk of developing BRD
  • Indicated for the treatment of infectious bovine keratoconjunctivitis (IBK) and for bovine foot rot (interdigital necrobacillosis)
  • Indicated for the treatment of swine respiratory disease (SRD) and for the control of SRD in groups of pigs where SRD has been diagnosed
  • For subcutaneous injection in beef and nonlactating dairy cattle and intramuscular injection in swine only
  • Not for use in female dairy cattle 20 months of age or older or in calves to be processed for veal
  • Slaughter withdraw: cattle within 18 days from the last treatment; swine within 5 days from last treatment